These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20096896)

  • 1. Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.
    Yilmaz Y; Alahdab YO; Yonal O; Kurt R; Kedrah AE; Celikel CA; Ozdogan O; Duman D; Imeryuz N; Avsar E; Kalayci C
    Metabolism; 2010 Sep; 59(9):1327-30. PubMed ID: 20096896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
    Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
    J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
    Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
    Hossain N; Afendy A; Stepanova M; Nader F; Srishord M; Rafiq N; Goodman Z; Younossi Z
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.
    Aktas B; Yilmaz Y; Eren F; Yonal O; Kurt R; Alahdab YO; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
    Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE
    J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma apelin levels in subjects with nonalcoholic fatty liver disease.
    Ercin CN; Dogru T; Tapan S; Kara M; Haymana C; Karadurmus N; Karslioglu Y; Acikel C
    Metabolism; 2010 Jul; 59(7):977-81. PubMed ID: 20045153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis.
    Miyaaki H; Ichikawa T; Nakao K; Yatsuhashi H; Furukawa R; Ohba K; Omagari K; Kusumoto Y; Yanagi K; Inoue O; Kinoshita N; Ishibashi H; Yano M; Eguchi K
    Liver Int; 2008 Apr; 28(4):519-24. PubMed ID: 17976158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension.
    Sorrentino P; Terracciano L; D'Angelo S; Ferbo U; Bracigliano A; Vecchione R
    Am J Gastroenterol; 2010 Feb; 105(2):336-44. PubMed ID: 19861959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
    Villanova N; Moscatiello S; Ramilli S; Bugianesi E; Magalotti D; Vanni E; Zoli M; Marchesini G
    Hepatology; 2005 Aug; 42(2):473-80. PubMed ID: 15981216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.
    Yilmaz Y; Ulukaya E; Atug O; Dolar E
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1247-51. PubMed ID: 19474742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.